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Background: The objective of this investigation was to develop a new type of solid dispersion 
in the form of core-sheath nanofibers using coaxial electrospinning for poorly water-soluble 
drugs. Different functional ingredients can be placed in various parts of core-sheath nanofibers 
to improve synergistically the dissolution and permeation properties of encapsulated drugs and 
to enable drugs to exert their actions.
Methods: Using acyclovir as a model drug, polyvinylpyrrolidone as the hydrophilic filament-
forming polymer matrix, sodium dodecyl sulfate as a transmembrane enhancer, and sucralose as 
a sweetener, core-sheath nanofibers were successfully prepared, with the sheath part consisting 
of polyvinylpyrrolidone, sodium dodecyl sulfate, and sucralose, and the core part composed of 
polyvinylpyrrolidone and acyclovir.
Results: The core-sheath nanofibers had an average diameter of 410 ± 94 nm with a uniform 
structure and smooth surface. Differential scanning calorimetry and x-ray diffraction results 
demonstrated that acyclovir, sodium dodecyl sulfate, and sucralose were well distributed in the 
polyvinylpyrrolidone matrix in an amorphous state due to favoring of second-order interactions. 
In vitro dissolution and permeation studies showed that the core-sheath nanofiber solid dispersions 
could rapidly release acyclovir within one minute, with an over six-fold increased permeation 
rate across the sublingual mucosa compared with that of crude acyclovir particles.
Conclusion: The study reported here provides an example of the systematic design, preparation, 
characterization, and application of a novel type of solid dispersion consisting of multiple 
components and structural characteristics.
Keywords: core-sheath nanofibers, solid dispersion, coaxial electrospinning, poorly 
water-soluble drug, dissolution, permeation
Introduction
Nanomedicine is a new field and an offshoot of nanotechnology, which focuses on 
the new properties of medical materials gained when structures are controlled at the 
atomic and molecular levels, leading to significantly changed properties distinct from 
traditional science fields.1 Nano drug delivery systems, as a subset of nanomedicine, 
have shown great potential in meeting many difficult pharmaceutical challenges, such 
as effective absorption of poorly water-soluble drugs, targeting cancer, oral vaccine and 
protein delivery, gene therapy, combating multidrug resistance, and trans blood–brain 
barrier drug delivery systems.2,3
Electrospinning is a simple and straightforward process for generating nanofibers. 
The popularity of this system is due to its ease of implementation, capability of being 
used with a variety of materials, convenience in obtaining composites of multiple 
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components, and with secondary microstructures (such as 
core-sheath, side-by-side, and island-in-sea). The applications 
of electrospun products are expanding, especially in areas 
relating to tissue engineering and drug delivery.4–8
Solid dispersion is one of the more promising strategies 
to improve the oral bioavailability of poorly water-soluble 
drugs, and is mainly obtained by two traditional methods, ie, 
melting and solvent evaporation.9–14 Over several decades, 
research concerning the development of solid dispersions and 
related fabrication processes has been widely reported, and 
a few solid dispersion products have already been marketed. 
Recently, it has been shown that the dissolution profile can be 
enhanced if the carrier has surface activity or self-emulsifying 
properties. Therefore, third-generation solid dispersions have 
been developed, usually consisting of an active pharmaceu-
tical ingredient, an amorphous polymer, and a surfactant. 
The objective of this new generation of solid dispersions 
is to achieve a higher degree of bioavailability for poorly 
soluble drugs that stabilize the solid dispersion, so avoiding 
drug recrystallization.15–17 However, all the reported solid 
dispersions, as intermediate formulations, are complexes 
or amorphous hybrids of two or multiple components and 
often lack secondary microstructural characteristics. If solid 
dispersions are designed with secondary structures, then this 
approach may not only provide greater physical stability, so 
avoiding recrystallization, but may also have new properties 
because of tactical deposition of varying functional ingredi-
ents in different locations within the solid dispersion.
Electrospinning, which has the shared characteristics of 
both electrospraying and conventional solution dry spinning 
of fibers, is inherently an appropriate method for preparing 
solid dispersions.18–20 Correspondingly, electrospun nanofibers 
can be good solid dispersion products. The fast-drying 
electrospinning process is able to “freeze” drug molecules 
randomly in the solid polymer fiber matrix into a state 
comparable with that in a liquid form. This is very useful for 
preventing phase separation, eg, recrystallization of either 
drug or matrix during removal of solvents.15–20 Exploitation 
of electrospinning in preparing solid dispersions is at present 
still somewhat limited, in that all the reported solid dispersions 
are produced by single fluid electrospinning and the nanofiber-
based solid dispersions formed invariably do not have structural 
characteristics.16–20 Over the past few years, electrospinning 
technology has evolved from using single, coaxial, and side-
by-side electrospinning, to adopting multiple fluid systems. 
These techniques allow the formation of new types of 
sophisticated nanofibers with well defined microstructures, 
novel morphologies, and/or new functions.21–25
Among all the different types of electrospinning 
processes, coaxial electrospinning, in which a concentric 
spinneret can accommodate two different liquids, is regarded 
as one of the most significant breakthroughs in the field.26–28 
It has been applied in controlling secondary structures of 
nanofibers, encapsulating drugs or biological agents into 
polymeric nanofibers, fabricating polymeric microtubes, 
preparing nanofibers from materials that lack filament-
forming properties, and enclosing functional liquids within 
the fiber matrix.29–33 Through modifications, nanofiber 
diameters can be manipulated for controlling the size of 
self-assembled nanoparticles, preparing ultrafine structures 
from concentrated polymer solutions, and improving nano-
fiber quality systematically.34–39
Based on the above knowledge, we report on the 
formation of a novel solid dispersion in the form of core-
sheath nanofibers produced using a coaxial electrospinning 
process. We believe that this is the first investigation of nano 
solid dispersions consisting of multiple components, with 
each constituent having its own spatial deposition in the 
nanofibers and the resulting format influencing functional 
characteristics.
Materials and methods
Materials
Polyvinylpyrrolidone (PVP) K60 (molecular weight 360,000) 
was purchased from BASF Corporation (Shanghai, China), 
acyclovir from Zhejiang Charioteer Pharmaceutical Company 
(Hangzhou, China), and sucralose and sodium dodecyl sulfate 
(SDS) from Sinopharm Chemical Reagent Co, Ltd (Shanghai, 
China). N,N-dimethylacetamide (DMAc) and anhydrous 
ethanol were provided by Shanghai Shiyi Chemicals Reagent 
Co, Ltd (Shanghai, China). All chemicals used were analytical 
grade. Water was double-distilled just before use.
Coaxial electrospinning process
A codissolving solution of 10% (w/v) PVP and 2% (w/v) 
acyclovir in a mixed solvent of DMAc:ethanol (4:6, v:v) 
was used as a core fluid. The electrospinnable sheath liquid 
consisted of 10% (w/v) PVP, 0.5% (w/v) SDS, and 0.2% (w/v) 
sucralose in a mixed solvent of water:ethanol (2:8, v:v).
A concentric spinneret with a coplanar inner and outer 
capillary was used to carry out the coaxial electrospinning.36 
Two syringe pumps (KDS100 and KDS200, Cole-Parmer, 
Vernon Hills, IL) were used to drive the sheath and core 
fluids at the same flow rate of 1.0 mL/hour. A metal clip was 
used to connect the spinneret with the high voltage supply 
(Shanghai Sute Electrical Co, Ltd, Shanghai, China) and the 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3272
Yu et alInternational Journal of Nanomedicine 2011:6
applied voltage was 12 kV . The nanofibers were collected 
on a metal collector wrapped with aluminum foil and kept 
at a fixed distance of 20 cm away from the needle tip of the 
spinneret. The coaxial processes were recorded using a digi-
tal video recorder (PowerShot A640, Canon, Japan) under 
magnification of 11× .
Characterization
The morphology of the surface and cross-sections of the 
core-sheath nanofibers were assessed using a S-4800 field-
emission scanning electron microscope (FESEM, Hitachi, 
Japan). The average fiber diameter was determined by 
measuring diameters of nanofibers over 100 points from the 
FESEM images using Image J software (National Institutes 
of Health, Bethesda, MD). Before carbon-coating, cross-
sections of the nanofiber mats were prepared by placing 
them into liquid nitrogen for over 15 minutes before manual 
breaking.
Transmission electron microscopy images of the samples 
were taken on a JEM 2100F FESEM (JEOL, Tokyo, Japan). 
Transmission electron microscopy samples of core-sheath 
nanofibers were prepared by fixing a lacey carbon-coated 
copper grid on the metal collector. Nanofibers were spun 
directly onto the grid.
Physical status of components  
and their interactions
Differential scanning calorimetry (DSC) analyses were 
carried out using an MDSC 2910 differential scanning 
calorimeter (TA Instruments Co, New Castle, DE). Sealed 
samples were heated at 10°C per minute from ambient 
  temperature (21°C) to 300°C. The nitrogen gas flow rate 
was 40 mL/minute.
X-ray diffraction analysis were obtained on a D/Max-BR 
diffractometer (RigaKu, Japan) with Cu Kα radiation in the 
2θ range of 5°–60° at 40 mV and 300 mA.
Attenuated total reflectance Fourier transform infrared 
(ATR-FTIR) analysis was carried out on a Nicolet-Nexus 
670 FTIR spectrometer (Nicolet Instrument Corporation, 
Madison, WI) over the range 500–4000 cm−1 and a resolution 
of 2 cm−1.
In vitro dissolution and permeation tests
The in vitro dissolution studies were carried out according 
to the Chinese Pharmacopeia (2005 ED) Method II, and 
a paddle method using a RCZ-8A dissolution apparatus 
(Tianjin University Radio Factory, China) was carried out. 
Core-sheath nanofibers (227 mg) or 20 mg of crude acyclovir 
particles (,100 µm) were placed in 600 mL of phosphate-
buffered solution (pH 6.8, 0.1 M) at 37°C ± 1°C and 50 rpm, 
in sink conditions of C , 0.2Cs. At predetermined time 
intervals, 5.0 mL samples were withdrawn and replaced with 
fresh medium to maintain a constant volume. After filtration 
through a 0.22 µm membrane (Millipore, Bedford, MA) and 
appropriate dilution with phosphate-buffered solution, the 
sample solutions were analyzed at 252 nm using an ultraviolet 
spectrophotometer (Unico Instrument Co, Ltd, Shanghai, 
China). All measurements were carried out in triplicate.
In vitro buccal permeation studies
The in vitro permeation studies were performed using 
a RYJ-6A diffusion test apparatus (Shanghai Huanghai 
Drug Control Instrument Co, Ltd), in which material was 
mounted on six Keshary-Chien glass diffusion cells and a 
water bath system that maintained a constant temperature of 
37°C ± 0.2°C. Each cell had a diffusion area of 2.60 cm2 and 
the receptor compartment had a capacity of 7.2 mL.
Porcine sublingual mucosa obtained from a local abattoir 
was mounted between the donor and receptor compartments 
of the diffusion cells, with the mucosal surface uppermost. 
This was performed within 2 hours of slaughter. Each donor 
compartment was filled with 1 mL of phosphate-buffered 
solution, and the hydrodynamics in the receptor compartment 
were maintained by stirring with a Teflon-coated magnetic 
bead at 100 rpm. The sublingual membranes were equili-
brated for 30 minutes before permeation tests.
Core-sheath nanofibers (1.14 mg) or 0.1 mg of crude 
acyclovir particles (,100 µm) were placed on the mucosal 
surface. Samples (1 mL) were withdrawn from the receptor 
compartment at timed intervals, filtered through a 0.22 µm 
membrane (Millipore) and absorption was measured at 
252 nm as before. All measurements were carried out in 
triplicate.
Results and discussion
Coaxial electrospinning
A schematic diagram of the coaxial electrospinning process 
and digital pictures of the process are shown in Figure 1. 
Coaxial electrospinning appeared to proceed smoothly under 
the conditions used. Acyclovir, a poorly water-soluble drug, 
has a high melting point (257°C) and also has poor solubil-
ity in a series of typical organic solvents, such as ethanol, 
methanol, chloroform, and acetone. There are no previous 
reports of the use of this drug in solid dispersions using 
traditional melt and solvent evaporation methods. Although 
acyclovir is soluble in DMAc, PVP cannot be electrospun 
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under these conditions due to its high boiling point (166°C) 
and poor volatility, thus it is impossible to prepare nanofiber 
solid dispersions of multiple components using single fluid 
electrospinning. This is due to the lack of cosolubility of the 
components or good electrospinnability.
For coaxial electrospinning, the core solution does not 
need to have electrospinnability, and the sheath solution acts 
as a guide and surrounds the core liquid. The sheath solution 
is critical, and the sheath polymer-solvent system selected 
should be electrospinnable by itself to facilitate formation of 
a core-sheath structure in the nanofibers.40–42 Thus, although 
the core solution consisting of 10% (w/v) PVP and 2% (w/v) 
acyclovir in a mixed solvent of DMAc:ethanol (4:6, v:v) 
was nonelectrospinnable, the electrospinnable sheath fluid 
consisting of 10% (w/v) PVP, 0.5% (w/v) SDS, and 0.2% 
(w/v) sucralose in a mixed solvent of water:ethanol (2:8, v:v) 
was able to ensure a smooth coaxial electrospinning process 
and formation of core-sheath nanofibers.
On the other hand, the critical voltage applied to a fluid 
to initiate Taylor cone formation and the straight thinning 
jet (Vc) has a close relationship with the surface tension and 
conductivity of fluid:43
  V
d
c ~
γ
ε
2
R
where Vc is the critical voltage for a jet emanating from the 
meniscus tip, d is the electrode separation, ε is the permittivity, 
γ is the surface tension, and R is the principal curvature of the 
liquid meniscus. The addition of SDS and sucralose to the sheath 
solution would reduce the surface tension and increase the per-
mittivity of the sheath fluid, and thus in turn decrease the applied 
voltage value needed to initiate coaxial electrospinning.
Morphology
Figure 2A and B show FESEM images of the surface 
and cross-section of the core-sheath nanofiber mats. 
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Figure 1 Schematic diagram of the coaxial electrospinning process (A) and digital pictures of the process (B).
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Figure 2 Characterization of the electrospun core-sheath nanofibers. (A) FESEM images of nanofiber surfaces; (B) FESEM images of nanofiber cross-sections; (C) distribution 
of nanofiber diameters; (D) TEM images of the fiber core-sheath structure. 
Abbreviations: FESEM, field emission scanning electron microscope; TEM, transmission electron microscopy.
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The nanofibers had a uniform structure without beads-on-a-
string morphology. They had smooth surfaces and the matrix 
was free of any separating particles. The nanofibers were 
evenly distributed, with an average diameter of 410 ± 94 nm 
(Figure 2C).
Transmission electron microscopy images (Figure 2D) 
clearly demonstrate the core-sheath structure of the 
nanofibers, and the uniform gray shading of the sheath and 
core parts of the nanofibers indicate that acyclovir is evenly 
distributed in the PVP matrix in the core part and SDS and 
sucralose are distributed in the PVP matrix in the sheath 
region.
Physical status of components  
in electrospun fibers
DSC and x-ray diffraction tests were undertaken to determine 
the physical status of the components contained in the core-
sheath nanofibers. DSC thermograms are shown (Figure 3), 
and the DSC curves of pure acyclovir and sucralose show a 
single endothermic response corresponding to melting points 
of 257°C and 130°C, respectively. SDS had a melting point 
of 182°C followed by a decomposing temperature of 213°C. 
As an amorphous polymer, PVP K60 did not show any fusion 
peaks or phase transitions, apart from a broad endotherm, 
this being due to dehydration, and lying between 80°C and 
120°C, with a peak at 85°C.44
DSC thermograms of nanofibers did not exhibit any melt-
ing peaks for small molecules. The nanofibers had a broad 
endotherm ranging from about 60°C to 100°C with a peak 
at 79°C. However, the decomposition bands of SDS in the 
core-sheath nanofibers were narrower and higher than that of 
pure SDS. The peak temperatures of decomposition shifted 
from 204°C. These results suggest that acyclovir, SDS, and 
sucralose were no longer present as a crystalline material 
but that their respective parts had been converted into an 
amorphous state in the core-sheath nanofibers.
As shown in Figure 4, the presence of numerous distinct 
peaks in the x-ray diffraction patterns indicated that acyclovir, 
sucralose, and SDS were present as crystalline materials with 
characteristic diffraction peaks. The PVP diffraction exhib-
ited a diffuse background pattern with two diffraction halos, 
indicating that the polymer was amorphous.45   Similarly, the 
results of DSC and x-ray diffraction demonstrated that the 
small functional molecules (acyclovir, sucralose, and SDS) 
were widely distributed in the PVP matrix and were present 
in a complex manner whereby the original structure of the 
pure materials was lost.
Secondary interactions  
among components
Compatibility between components is essential for pro-
ducing nanofibers of high quality and stability. Often the 
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Figure  3  Differential  scanning  calorimetry  thermograms  of  the  components 
(acyclovir,  PVP,  SDS,  and  sucralose)  and  their  core-sheath  nanofibers  under  a 
heating rate of 10°C per minute and a nitrogen gas flow rate of 40 mL/minute. 
Abbreviations: PVP, polyvinylpyrrolidone; SDS, sodium dodecyl sulfate.
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Figure 4 X-ray diffraction patterns of the components (acyclovir, PVP, SDS, and 
sucralose) and their core-sheath nanofibers with CuKα radiation at 40 mV and 
300 mA. 
Abbreviations: PVP, polyvinylpyrrolidone; SDS, sodium dodecyl sulfate.
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  second-order interactions, such as hydrogen bonding, elec-
trostatic interactions, and hydrophobic interactions would 
improve compatibility.46 The molecular structures of the 
four components are shown (Figure 5A). Acyclovir and 
sucralose molecules contain free hydroxyl groups which 
could act as potential proton donors for hydrogen bonding. 
SDS has S=O groups and PVP has carbonyl groups which 
could act as proton receptors. Therefore, it can be postulated 
that hydrogen bonding can occur within the core-sheath 
nanofibers through interactions determined by the specific 
presence of these groups.
Acyclovir molecules have both –OH groups and –C=O 
groups, and so hydrogen bonds can form between the drug 
molecules (Figure 5B). This can be verified from the ATR-
FTIR spectra in which sharp peaks are visible for pure 
crystalline acyclovir at 1698 cm−1 and 1632 cm−1 (Figure 6), 
representing the stretching vibration of –C=O groups for 
the different states. However, all the peaks for acyclovir were 
absent in the core-sheath nanofibers when samples were 
evaluated using ATR-FTIR spectra. Only one large peak at 
1654 cm−1 can be identified for the core-sheath nanofibers. 
This result indicates that hydrogen bonding between the 
PVP carbonyl group and the oxhydryl group of the acyclo-
vir molecule occurs (Figure 5B). In respect to acyclovir, by 
interacting with the polymer, the structure is less likely to 
form the dimers that are necessary for constructing a crystal 
lattice.
The disappearance of absorbance of –C=O groups in 
acyclovir, the shift to a lower wavenumber of peaks assigned 
to the C=O stretching vibrations in PVP (from 1663 cm−1 to 
1654 cm−1 for the core-sheath nanofibers), and the disappear-
ance of multiple peaks within the 3000–4000 cm−1 regions 
(related to the O–H stretching vibrations in sucralose and 
acyclovir) together demonstrate that hydrogen bonding was 
occurring.
The absorption of SDS (C–H stretching) at 2917 cm−1 and 
2850 cm−1 and PVP (C–H stretching) at 2954 cm−1 were not 
present in the core-sheath nanofibers when compared with 
single SDS and PVP. However, a broader and weaker band 
at 2917 cm−1 appeared, which is indicative of hydrophobic 
interactions between the PVP and SDS molecules. Although 
electrostatic interactions cannot be determined from the ATR-
FTIR spectra, they do exist between the negatively charged 
SDS head group and the nitrogen atom on the   pyrrolidone 
ring of PVP47,48 and also between the negatively charged PVP 
oxygen (N+=C–O–) and the electron-poor C–1′ of SDS,49,50 
as shown in Figure 5A.
A
PVP
SDS
ACY
Sucralose
O
n
CH CH2
O
OO O
O
O OH
CI
OH OH
HO
O O
S
Na
OH N
CH2OH
CH2Cl
CH2Cl
N
N HN
H2N
H2N
H2N
HN
HN
O
O
O
O
O
O
O
O
O
OH
N
N
N
N
N
HN
CH2 CH
H
n
N
N
N
N N
H
H2N
B
NO
I ⊕ ⊕
⊕
Figure 5 Molecular structures of the components (A) and hydrogen bonding between acyclovir molecules and between acyclovir and PVP molecules (B). 
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Based on the evidence presented, it is postulated that 
a combination of hydrogen bonding and hydrophobic and 
electrostatic forces provides an environment that stabilizes 
the structure, thereby giving a high degree of compatibil-
ity between the components that make up the core-sheath 
nanofibers. This, in turn, creates a homogeneous structure 
which influences both the stability of the solid dispersion 
and even distribution of the drug, so facilitating dissolution 
of acyclovir from the nanofibers.
In vitro dissolution properties
Acyclovir has an ultraviolet absorbance peak at 252 nm, 
whereas the other components, ie, PVP, SDS, and sucralose, 
have no absorbance at this wavelength. Using this param-
eter, the content of acyclovir was determined by ultraviolet 
spectroscopy, and samples were calculated from a calibration 
curve A = 0.05908C + 0.00515 (R = 0.9999), where C is the 
concentration of acyclovir (µg/mL) and A is absorbance at 
252 nm (linear range 2–20 µg/mL).
A comparison of the in vitro dissolution profile for 
acyclovir from core-sheath nanofibers and that for crude 
acyclovir particles (#100 µm) is shown in Figure 7. The 
nanofiber mats released all the encapsulated acyclovir within 
one minute, whereas only 40.5% of the drug was released 
from acyclovir particles left in the dissolution media for 
one hour.
Methods for improving drug solubility and dissolution 
rate continue to be sought.51,52 Generally, these protocols 
have been guided by the Noyes-Whitney equation,53,54 which 
defines the dissolution rate (dX/dt) as follows:
  dX dt AD CX V /( /) (/ ) =× ×− δ 0
where X is the amount of drug in solution, t is time, A is the 
effective surface area, D is the diffusion coefficient of the 
drug, δ is the effective diffusion boundary layer, C0 is the 
saturation solubility of the drug, and V is the volume of 
the dissolution medium. Based on this equation, the rate of 
  dissolution is directly proportional to the surface area of the 
drug and to the drug concentration gradients in the   dissolution 
medium, but is inversely proportional to the diffusion layer 
thickness at the solid-liquid interface.
Core-sheath nanofibers have essential properties for 
improving the dissolution rates of poorly water-soluble 
drugs: the nanofibers have a small diameter and a high 
surface to volume ratio, which means that there is a large 
surface area for the drug to be in contact with the dissolu-
tion media; the nanofiber assembly has a three-dimensional 
continuous web structure which provides great porosity to 
facilitate fast mass transformation of solvent and drug mol-
ecules from or into the bulk dissolution media; the nanoscale 
diameter of the nanofibers which greatly decreases the diffu-
sion layer   thickness with the uniform PVP-SDS-sucralose/
PVP-  acyclovir complex which can improve drug   wettability; 
and the fast dissolution of the core-sheath nanofibers, which 
could   augment local concentrations of supersaturated drug 
solution, especially in the presence of PVP and SDS, and 
thus   correspondingly increases the drug gradients for 
rapid   diffusion of molecules to the dissolution media. The 
combined synergistic effect of nanosizing of fibers, the 
continuous web structure of the nanofibers, and molecular 
distribution of drug in the filament-forming matrix provide 
these structures with unique properties for improving the 
dissolution rate of acyclovir.
In vitro permeation properties
Comparison of the in vitro permeation profiles for acyclovir 
from core-sheath nanofibers and crude acyclovir particles is 
shown in Figure 8. The cumulative permeation percentages 
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Figure 7 In vitro dissolution profiles of the acyclovir powders and core-sheath 
nanofiber solid dispersions.
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after half an hour for the core-sheath nanofibers and crude 
acyclovir particles were 68.3% and 11.4%, respectively. 
  Regression values from the linear release-time equations were 
estimated for the core-sheath nanofibers and crude acyclovir 
particles. These were Q = 2.3095t + 1.3809 (R = 0.9915, 
t # 30 minutes) and Q = 0.3408t + 1.1024 (R = 0.99089, 
t # 120 minutes), respectively, where Q is total permeation of 
acyclovir in µg and t is time in minutes. Thus, the core-sheath 
nanofibers and crude acyclovir particles had a permeation 
rate of 0.89 and 0.13 µg/min/cm, respectively.
The core-sheath nanofibers yielded a permeation rate 
of acyclovir that was over six-fold faster than that of the 
crude particles. The faster permeation rates from the core-
sheath nanofibers can be explained in terms of permeability 
across the sublingual mucosa being a passive diffusion 
process, and hence faster dissolution of acyclovir would 
lead to an increased concentration gradient of drug at the 
mucosal surface. This would facilitate rapid partition-
ing of drug into the sublingual mucosa and subsequent 
  permeation.55 The SDS released from the nanofibers may 
also improve permeation by extracting intercellular lipids 
that act as a rate-limiting barrier to the transport of acy-
clovir molecules.56
In addition to the advantages of improved solubility 
behavior and permeation properties of acyclovir, core-sheath 
solid dispersions can be post-processed more easily because 
they have good drug stability due to the steric constraints 
provided by the small diameter of the nanofibers and the 
“nanocoating” effect of the sheath on the core drug-loaded 
region. This would effectively avoid recrystallization and 
possible growth of a crystal lattice.
Within this context, sucralose, an artificial sweetener, 
has recently gained popularity because it is 600 times 
more effective by weight compared with sucrose and 
does not have the bitter aftertaste characteristic of many 
non-nutritive sweeteners. The US Food and Drug Admin-
istration has approved sucralose, and it is now applied as 
a general   purpose sweetener in foods,   beverages, dietary 
  supplements, and medical foods.57,58 The positioning of 
sucralose in the sheath component would effectively 
provide an acceptable taste for patients if solid dispersions 
are developed further as oral drug delivery systems. 
On the other hand, researchers are now focusing on 
the mass preparation of nanofibers for scaling up,59,60 
so the   development of core-sheath solid dispersions as 
demonstrated here may offer a solution for development 
of commercial products that involve poorly water-soluble 
active ingredients.
Conclusion
This study has demonstrated that it is possible to prepare a 
solid dispersion in the form of core-sheath nanofibers using 
a coaxial electrospinning process for poorly water-soluble 
drugs. Different functional ingredients can be placed in   various 
locations in the core-sheath nanofibers and provide unique and 
specific properties for the nanofiber system. The core-sheath 
nanofibers had an average diameter of 410 ± 94 nm with a 
uniform structure and smooth surface, as demonstrated by 
FESEM and transmission electron microscopy. X-ray diffrac-
tion and DSC results demonstrated that the acyclovir, solid 
dispersions, and sucralose were distributed in the core/sheath 
PVP matrix in an amorphous manner. The ATR-FTIR spectra 
verified second-order interactions suggesting that hydrogen 
bonding, electrostatic interactions, and hydrophobic interac-
tions occurred among the components, and that these nonco-
valent forces are likely to play a significant role in promoting 
the homogeneity of the structure. In vitro dissolution and 
permeation tests showed that the core-sheath nanofiber solid 
dispersions could rapidly release all their acyclovir within 
one minute, with a six-fold greater permeation rate across the 
sublingual mucosa compared with crude acyclovir particles. 
The study also provides an example of the systematic design, 
preparation, characterization, and application of a novel type 
of solid dispersion consisting of multiple components and with 
unique structure characteristics. This nanofiber structure has 
the potential to enhance the dissolution and permeation per-
formance of a series of poorly water-soluble drugs, and could 
be developed further as a novel oral drug delivery system.
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